Can UV light beat Drug-Resistant ringworm?
NCT ID NCT07242703
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether narrow-band ultraviolet B (NB-UVB) light therapy can help people with ringworm infections that don't get better with standard antifungal drugs. The trial will enroll 36 adults who have had at least two relapses in the past six months. Half will receive UVB light alone, and the other half will continue standard antifungal treatment. Researchers will measure how well the infection clears and whether it stays away.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- narrow-band ultraviolet B (NB-UVB) phototherapy
- What this could lead to
- If it works, this could offer a new treatment option for people with ringworm that keeps coming back or doesn't respond to standard antifungal pills.
- What could go wrong
- This is a very small, early-stage trial with only 36 people. It's not yet recruiting, so results are far off. UVB light can cause skin burns or increase skin cancer risk with long-term use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNGAL RESISTANCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.